Literature DB >> 5270253

Methoxy-9-ellipticine lactate. 3. Clinical screening: its action in acute myeloblastic leukaemia.

G Mathé, M Hayat, F De Vassal, L Schwarzenberg, M Schneider, J R Schlumberger, C Jasmin, C Rosenfeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5270253

Source DB:  PubMed          Journal:  Rev Eur Etud Clin Biol        ISSN: 0035-3019


× No keyword cloud information.
  7 in total

1.  Methoxy-9-ellipticine lactate in refractory acute myeloid leukaemia.

Authors:  B M Ansari; E N Thompson
Journal:  Postgrad Med J       Date:  1975-02       Impact factor: 2.401

Review 2.  New cancer chemotherapy drugs in Europe.

Authors:  G Mathé; L M van Putten
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.

Authors:  J B Le Pecq; C Gosse; C Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

4.  Biotransformation of ellipticine into 5-formyl ellipticine by Choisya ternata strains.

Authors:  K Kouadio; M Rideau; C Ganser; J C Chénieux; C Viel
Journal:  Plant Cell Rep       Date:  1984-10       Impact factor: 4.570

5.  Histamine-releasing properties of hydroxy-9-methyl-2-ellipticinium acetate.

Authors:  A Eschalier; C Advenier; B Lebel; C Burtin; J Lavarenne
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Correlations between experimental chemotherapy in the murine glioma and effectiveness of clinical therapy regimens.

Authors:  V A Levin; C B Wilson
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

7.  A novel structural derivative of natural alkaloid ellipticine, MDPSQ, induces necrosis in leukemic cells.

Authors:  M S Shahabuddin; Mridula Nambiar; Balaji T Moorthy; Prakruthi L Naik; Bibha Choudhary; Gopal M Advirao; Sathees C Raghavan
Journal:  Invest New Drugs       Date:  2010-01-13       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.